Back to search

Ireland· IE-PA-EU/1/99/120/002

Ammonaps 500 mg Tablets

A sodium phenylbutyrate product containing sodium phenylbutyrate, registered in Ireland by Immedica Pharma AB. The same ATC class is registered in 14 of our 19 countries.

ATC A16AX03

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedAmmonaps 500 mg TabletsATCA16AX03REGISTER NO.IE-PA-EU/1/99/120/002PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Sodium phenylbutyrate is registered in 14 of 19 countries.

Countries holding a registration under ATC A16AX03 (sodium phenylbutyrate), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Sodium phenylbutyrate · ATC A16AX03

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sodium phenylbutyrate costs, country by country.

Normalised to the WHO defined daily dose (20 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Sodium phenylbutyrate · price per daily dose (20 g)

USD · FX 28 Sept 2026

  • CZ Czechia$0.46
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Sodium phenylbutyrate
Manufacturer
Immedica Pharma AB
Country
Ireland (IE)
ATC code
A16AX03
ATC class
Sodium phenylbutyrate
Defined daily dose
20 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/99/120/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sodium phenylbutyrate in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium phenylbutyrate products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Ammonaps, Pheburane
  • Liechtenstein · Ammonaps
  • Norway · Ammonaps, Pheburane

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/00d9d027-1a97-48ff-afa7-790a1133f597
GET /v1/drugs/00d9d027-1a97-48ff-afa7-790a1133f597?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "A16AX03"
  ],
  "strength": null,
  "pa_number": "EU/1/99/120/002",
  "substances": [
    "Sodium phenylbutyrate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "08/12/1999",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about sodium phenylbutyrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.